Search - tctmd.com

Displaying 421 - 440 of 786

Sort: Relevancy | Date

Presentation ACC 2018

MANAGE: Dabigatran in Myocardial Injury After Noncardiac Surgery

Presenter: Philip Devereaux

March 12, 2018

News Conference News ACC 2018

Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis

Todd Neale

March 12, 2018

Presentation ACC 2018

High Rate of Amputation and Death after Major Adverse Limb Events (MALE) in Peripheral Artery Disease: Results from COMPASS

Presenter: Sonia S. Anand

March 11, 2018

Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making – Analysis from DEFINE FLAIR

Presentation ACC 2018

Analysis from DEFINE FLAIR Trial

Presenter: Manesh R. Patel

March 11, 2018

Presentation ACC 2018

One-year Clinical Outcomes of the Bio-engineered COMBO stent: Primary Results from the 3614 All-comer Patients in the COMBO Collaboration

Presenter: Antonio Colombo

March 11, 2018

News Conference News ACC 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Michael O'Riordan

March 11, 2018

Presentation ACC 2018

Results of the SWAP (Switching Antiplatelet Therapy) - 4 Study

Presenter: Francesco Franchi

March 11, 2018

News Conference News ACC 2018

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

Shelley Wood

March 11, 2018

News Conference News ACC 2018

Thin Struts and ‘Pro-Healing’ Layer: COMBO Stent Sees Success at 1 Year

Yael L. Maxwell

March 11, 2018

News Conference News ACC 2018

Genetic Testing Influences Post-PCI Antiplatelet Prescriptions, but Other Factors Also Play a Role

Yael L. Maxwell

March 11, 2018

News Conference News ACC 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

Caitlin E. Cox

March 11, 2018

News Conference News ACC 2018

MANAGE Suggests Dabigatran Could Be Useful for Treating Myocardial Injury After Noncardiac Surgery

Todd Neale

March 11, 2018

Presentation ACC 2018

Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

Presenter: Ajay J. Kirtane

March 11, 2018

News Conference News ACC 2018

Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues

Michael O'Riordan

March 11, 2018

Presentation ACC 2018

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout and Cardiovascular Disease (The CARES Trial)

Presenter: William B. White

March 11, 2018

Presentation ACC 2018

Hospital Readmission Following Perioperative Myocardial Infarction Associated with Non-Cardiac Surgery

Presenter: Nathaniel R. Smilowitz

March 11, 2018

News Conference News ACC 2018

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

Shelley Wood

March 11, 2018

Presentation ACC 2018

The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome

Presenter: Philippe Gabriel Steg

March 10, 2018

News Conference News ACC 2018

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

Yael L. Maxwell

March 10, 2018

News Conference News ACC 2018

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

Shelley Wood

March 10, 2018

Advertisement

MANAGE: Dabigatran in Myocardial Injury After Noncardiac Surgery

Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis

High Rate of Amputation and Death after Major Adverse Limb Events (MALE) in Peripheral Artery Disease: Results from COMPASS

Analysis from DEFINE FLAIR Trial

One-year Clinical Outcomes of the Bio-engineered COMBO stent: Primary Results from the 3614 All-comer Patients in the COMBO Collaboration

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Results of the SWAP (Switching Antiplatelet Therapy) - 4 Study

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

Thin Struts and ‘Pro-Healing’ Layer: COMBO Stent Sees Success at 1 Year

Genetic Testing Influences Post-PCI Antiplatelet Prescriptions, but Other Factors Also Play a Role

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

MANAGE Suggests Dabigatran Could Be Useful for Treating Myocardial Injury After Noncardiac Surgery

Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout and Cardiovascular Disease (The CARES Trial)

Hospital Readmission Following Perioperative Myocardial Infarction Associated with Non-Cardiac Surgery

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content